All In Biotech

Drug Trial Radar · NCT03361865

Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

A Phase 3 Randomized, Double-Blind Trial of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) or Placebo in Participants With Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

Last checked: Nov 19, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

93

Actual

Start

Dec 4, 2017

Primary completion

Aug 9, 2018

Study completion Aug 4, 2020

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Dec 5, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to evaluate the efficacy and safety of pembrolizumab + epacadostat vs pembrolizumab + placebo in participants with cisplatin-ineligible urothelial carcinoma.

Conditions

  • UC (Urothelial Cancer)

Interventions

  • PembrolizumabDrug

    Pembrolizumab administered intravenously every 3 weeks.

  • EpacadostatDrug

    Epacadostat administered orally twice daily.

  • PlaceboDrug

    Matching placebo administered orally twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR) With Pembrolizumab + Epacadostat Versus Pembrolizumab + PlaceboTime frame: Week 9

Locations

143 sites in 18 countries. Site status is shown where the registry gives one.

  • Arizona Oncology Associates PC- HOPE

    Tucson, Arizona

  • University of California Irvine Medical Center

    Orange, California

  • Yale Cancer Center

    New Haven, Connecticut

  • Woodlands Medical Specialists, PA

    Pensacola, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Quincy Medical Group

    Quincy, Illinois

  • Massachusetts General Hospital

    Boston, Massachusetts

  • GU Research Network-Urology Cancer Center

    Omaha, Nebraska

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone

    New York, New York

  • Levine Cancer Institute

    Charlotte, North Carolina

  • Willamette Valley Cancer Institute and Research Center

    Eugene, Oregon

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • Medical University of South Carolina-Hollings Cancer Center

    Charleston, South Carolina

  • Tennessee Oncology, PLLC/The Sarah Cannon Research Institute

    Chattanooga, Tennessee

  • University of Tennessee Medical Center Knoxville

    Knoxville, Tennessee

  • Sarah Cannon Research Institute

    Nashville, Tennessee

  • Tennessee Oncology Nashville

    Nashville, Tennessee

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

  • Texas Oncology-Memorial City

    Houston, Texas

  • University of Washington

    Seattle, Washington

  • Adelaide Cancer Centre

    Kurralta Park, Australia

  • Macquarie University Hospital

    Macquarie Park, Australia

  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia

  • Southern Medical Day Care Centre

    Wollongong, New South Wales, Australia

  • Austin Health-Austin Hospital

    Heidelberg, Victoria, Australia

  • Institut Jules Bordet

    Brussels, Belgium

  • Grand Hopital de Charleroi - Site Notre Dame - Oncology

    Charleroi, Belgium

  • AZ Maria Middelares Gent

    Ghent, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Hopital de Jolimont

    Haine-Saint-Paul, Belgium

  • AZ Nikolaas

    Sint-Niklaas, Belgium

  • GZA Sint Augustinus

    Wilrijk, Belgium

  • Moncton Hospital - Horizon Health Network

    Moncton, New Brunswick, Canada

  • Cancer Centre of Southeastern Ontario at Kingston General Hospital

    Kingston, Ontario, Canada

  • The Ottawa Hospital Cancer Centre

    Ottawa, Ontario, Canada

  • Sunnybrook Health Science Centre

    Toronto, Ontario, Canada

  • CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont

    Montreal, Quebec, Canada

  • CHU de Quebec - Hotel-Dieu de Quebec

    Québec, Quebec, Canada

Showing 40 of 143 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.